Authors
Latest:
Resiliency and Posttraumatic Growth: Cultural Implications for PsychiatristsAcknowledging a patient's ability to grow and recover may help them feel more understood despite ongoing suffering.
Latest:
Adding Insult to Narcissistic Injury: Comorbidity of Narcissistic Personality Disorder and Major Depressive DisorderDiagnosing this intricate comorbidity demands a nuanced approach. Here's what you need to know.
Latest:
Zuranolone for the Treatment of Adults With Major Depressive DisorderThis randomized, placebo-controlled, phase 3 clinical trial showed that a 14-day treatment course of oral zuranolone 50 mg/day in MDD led to significantly greater improvements in depressive symptoms when compared with placebo.
Latest:
SPIRIT (Social Psychiatry Interested in Recovery from International Trauma) Voices Some Current ConcernsAll these events that occurred over the weekend bear social psychiatric weight.
Latest:
Brain Capital: An Emerging Investment OpportunityBrain Capital: a fresh approach to technologies and investing.
Latest:
Opportunities in Managing Treatment-Resistant Depression and Tardive DyskinesiaThis CME describes current strategies and recent advances in treatment.
Latest:
Physician Liability During COVID-19: What You Need to Know To Protect Your PracticeDoes the typical malpractice insurance policy cover COVID-related claims? That question and more answered.
Latest:
New-Onset Racism or Psychosis?Racism is not usually considered a psychotic symptom and therefore it is not often considered in the diagnosis of schizophrenia.
Latest:
Exploring Diagnostic Strategies in the Assessment of Mixed Affective StatesIn this CME article, examine how current DSM nosology defines the proper method of assessing a mixed-episode patient and which diagnostic labels to give them based on their presenting symptomatology.
Latest:
Brain Capital: An Emerging Investment OpportunityBrain Capital: a fresh approach to technologies and investing.
Latest:
What Does the Future Hold for Psychedelic-Assisted Psychotherapy?A growing body of scientific evidence suggests that mind-altering drugs, combined with psychotherapy, are effective treatments for some of the most stubborn psychiatric disorders.
Latest:
The Ethics of ReopeningAt the heart of reopening is protecting both population health and economic health.
Latest:
Market Yourself by Leveraging Digital PlatformsHaving an appropriate presence on social media can help your career.
Latest:
You Say Pain. I Say Addiction. Let’s Call the Whole Thing OffThis CME will inform clinicians with unique and much-needed skill sets in diagnosing substance use disorders and managing co-occurring chronic pain.
Latest:
Chemotherapy-Induced Psychosis in an AdolescentCheck out this case study to learn more about how viral infections might play a role in triggering psychotic disorders.
Latest:
10 Measures and Outcomes to Assess Progress in Eradicating RacismSuggestions to assess outcomes and measure success levels in combatting racism.
Latest:
Antidepressant Response: What’s DNA Got to Do With It?Research using data from the All of Us Research Program seeks to solve the mystery of what makes medications work for some and not others.
Latest:
Telling Humanity’s Brain Story: Insights From Brain CapitalWhich innovations can improve measurement, technology, investment, and public policy surrounding brain health?
Latest:
STAR*D’s Cumulative Remission Rate and Why It Still MattersContesters of STAR*D discuss the impact and relevance of the study's remission rates.
Latest:
Polypharmacy in Older AdultsClinicians should carefully weigh the risks and benefits of each prescribed medication for an older adult with neuropsychiatric diseases and periodically review all prescribed medications. Learn more here.
Latest:
Enhancing Patients' Motivation and Empowerment: A Resident’s PerspectiveEmpowerment has a significant correlation with patients’ overall mental and physical well-being, and has been central to the shift in conceptual framework of mental illness recovery towards a focus on resilience, strength, and control over one’s life.
Latest:
The Impact of Cannabis Use on Medication Adherence: A Particular Focus in PsychosisWhat is the effect of cannabis use on adherence to medications in patients with psychosis?
Latest:
Insights From the 2022 AAPL Annual MeetingThe American Academy of Psychiatry and the Law hosted its first in-person meeting in October 2022. Check out these highlights.
